Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon […]
Read More11.8 million people could lose health insurance under Senate GOP tax bill
WASHINGTON — Senate Republicans’ version of President Trump’s tax bill would lead to 11.8 million people losing health insurance over the next decade, according to a new report from the […]
Read MorePfizer to pay $60 million to settle claims that Biohaven paid kickbacks to doctors
Pfizer agreed to pay nearly $60 million to resolve allegations that its Biohaven Pharmaceuticals unit paid kickbacks to entice physicians to prescribe a migraine treatment. The alleged violations occurred before […]
Read MoreTasca Therapeutics, an oncology startup, launches with $52 million
Tasca Therapeutics, the first startup created by new VC firm Cure Ventures, has raised $52 million to develop a new breed of cancer therapies. Tasca is developing small molecule treatments […]
Read More